BRIEF published on 11/07/2024 at 09:11, 14 days 4 hours ago Analysis: Rubean AG's Performance and Future Prospects Sales Growth NuWays AG Rubean AG SoftPOS Mobile Payment
PRESS RELEASE published on 11/07/2024 at 09:06, 14 days 4 hours ago Original-Research: Rubean AG (von NuWays AG): Buy Rubean AG's Q3 figures meet expectations with 117% yoy sales growth driven by SoftPOS rollout. Market leader in Germany and Spain, serving various industries. Strong sales ramp-up ahead Sales Growth Rubean AG Market Leader Q3 Figures SoftPOS Rollout
BRIEF published on 11/05/2024 at 12:01, 16 days 1 hour ago Rubean AG Experiences Significant Turnover Increase in 2024 Rubean AG SoftPOS Solution Cost Efficiency Fintech Growth Deichmann Partnership
PRESS RELEASE published on 11/05/2024 at 11:56, 16 days 1 hour ago Rubean more than doubled its turnover in the first nine months of the year Fintech company Rubean AG reports 117% year-on-year revenue growth in the first nine months of 2024. Key success with Deichmann and expansion in Colombia Revenue Growth Fintech Rubean AG Colombia Deichmann
BRIEF published on 10/21/2024 at 16:48, 30 days 21 hours ago Rubean AG Enters South American Market South America Rubean AG PhonePOS Market Entry UN Conference
PRESS RELEASE published on 10/21/2024 at 16:43, 30 days 21 hours ago Rubean AG entered the South American market today Rubean AG enters South American market with PhonePOS solution at UN Biodiversity Conference in Cali, Colombia, enabling card payments via smartphone South America Rubean AG PhonePOS Solution UN Biodiversity Conference Cali Colombia
BRIEF published on 09/17/2024 at 09:07, 2 months 4 days ago NuWays AG Recommends "BUY" for Rubean AG Investment Mobile POS NuWays AG Growth Rubean AG
PRESS RELEASE published on 09/17/2024 at 09:02, 2 months 4 days ago Original-Research: Rubean AG (von NuWays AG): BUY NuWays AG releases updated research on Rubean AG, highlighting successful product roll-out, strong pipeline with major customer wins expected, and significant market potential in mPOS space NuWays AG Rubean AG Product Roll-out Customer Wins MPOS Market
BRIEF published on 07/18/2024 at 09:06, 4 months 3 days ago Rubean AG Reports Dynamic H1 Growth and Strategic Partnerships Strategic Partnerships Rubean AG SoftPOS Solution FY24 Outlook H1 Growth
PRESS RELEASE published on 07/18/2024 at 09:01, 4 months 3 days ago Original-Research: Rubean AG (von NuWays AG): BUY Rubean AG's H1 turnover rises by 370% yoy, FY23 figures meet estimates. Commerz Globalpay adopts Rubean's SoftPOS in Germany, driving optimism for strong FY24 growth Rubean AG Commerz Globalpay FY23 Figures SoftPOS Solution H1 Turnover
Published on 11/21/2024 at 13:30, 25 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 25 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 55 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 55 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 55 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 20 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 40 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 57 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 35 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 10 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 10 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
